KANGHONG - Trademark Details
Status: 700 - Registered
Serial Number
79245594
Registration Number
5876519
Word Mark
KANGHONG
Status
700 - Registered
Status Date
2019-10-08
Filing Date
2018-05-22
Registration Number
5876519
Registration Date
2019-10-08
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261121, 261701, 261705, 261709, 261725, 280103 - Rectangles that are completely or partially shaded. Straight line(s), band(s) or bar(s). Horizontal line(s), band(s) or bar(s). Curved line(s), band(s) or bar(s). Other lines, bands or bars. Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters.
Published for Opposition Date
2019-07-23
Attorney Name
Law Office Assigned Location Code
N30
Employee Name
MARINO, JENNIFER ELLEN
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
THE CHINESE CHARACTER THAT TRANSLITERATES TO "KANG"
Description of Mark
The mark consists of of a rounded chevron inside of a rectangle with rounded corners. To the right are two Chinese characters with a line underneath and the wording "KANGHONG" underneath the line.
Goods and Services
Mothproofing preparations; Radioactive substances in the nature of drugs for medical purposes; Chemico-pharmaceutical preparations for reducing blood fat; Chemico-pharmaceutical preparations for promoting sleep; Chemico-pharmaceutical preparations for sedation, anti-depression, tumor suppression; Chemico-pharmaceutical preparations for the treatment of diabetes, diseases of the central nervous system, diseases of the respiratory system, cardiovascular diseases and cancer; Chemico-pharmaceutical preparations used in eye surgery and intraocular surgery; Pharmaceutical preparations in the nature of tissues impregnated with pharmaceutical skin lotions; Depuratives for the body; Media for bacteriological cultures; Medicinal preparations for the mouth to be applied in the form of tablets; Semen for artificial insemination; Medicines for human purposes, namely, medicines for humans for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; Medicines for humans to treat or prevent diabetes, coughs, colds, influenza, headaches and allergic reactions; Vermin destroying preparations; Biochemical drug for medical purposes for the treatment of cancer and ophthalmic diseases; Suppositories; Pharmaceutical preparations in the form of liquids for the treatment of central nervous system diseases, tumors, diabetes, ophthalmic diseases; Pharmaceutical preparations in the form of liquids for the treatment of cancer; Disinfectants for hygiene purposes; Mosquito-repellent incense; Sanitary sterilizing preparations in the nature of tissues impregnated with sterilization preparations; Chemical conductors for electrocardiograph electrodes; Dental lacquer; Medicinal drinks in the nature of herb liqueurs; Pharmaceutical preparations used for the relief of pain and to reduce fever; Pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases, hemophilia, metabolic diseases, cancer, multiple sclerosis, urologic diseases, sexual dysfunction, osteoporosis, and climacteric diseases; Pharmaceutical preparations, namely, anticoagulants and platelet aggregation inhibitors; anti-infective pharmaceutical preparations; Pharmaceutical preparations, namely, ophthalmics; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Infusions for medical purposes for treating dermatological diseases; Gases for medical purposes; Wadding for medical purposes; Drugs for medical purposes, namely, pharmaceutical preparations for anti-depression, tumor suppression, relieving cough, reducing blood pressure; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment central nervous system diseases, asthma, diabetes, respiratory system diseases, cancer, cardiovascular diseases, gastrointestinal diseases, hyperlipidaemia and hypercholesteremia; Drugs for medical purposes, namely, pharmaceutical preparations used in eye surgery and intraocular surgery; Bath preparations for medical purposes; Diagnostic agents for medical purposes; Solutions for contact lenses; Crude drugs, namely pharmaceutical preparations for the treatment of central nervous system diseases, namely hypertension, hyperlipidemia, schizophrenia and melancholia, digestive system diseases, namely dyspepsia, chronic gastritis, chronic lithogenous cholecystitis, chronic cholecystitis and gall-stone, ophthalmology system diseases, namely wet Age-related Macular Degeneration (AMD), and other diseases, namely fever, irritability, red eyes, mouth sores, sore throat, swollen gums, constipation, pharyngitis, tonsillitis, gingivitis, upper respiratory infection (URI), acute bronchitis, diabetes and nephropathy; Pharmaceutical preparations in the form of injections for the treatment of central nervous system diseases, diabetes, fundus oculi disease and cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceutical preparations in the form of injections used in eye surgery and intraocular surgery; Traditional Chinese medicines for Chinese medicinal use, namely, dried Chinese boxthorn fruits, Chinese-date, pseudo-ginseng, Chinese angelica and ginseng; Traditional Chinese medicines for Chinese medicinal use, namely, dried Chinese boxthorn fruits, Chinese-date, pseudo-ginseng, Chinese angelica and ginseng sold as a kit in a Chinese medicine bag
Pseudo Mark
KANG HONG
Transliteration Statement
The non-Latin characters in the mark transliterate to "KANG HONG" and this has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-11-23
Primary Code
005
Current Trademark Owners
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Jennifer Sheehan Anderson
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1434664
International Registration Date
2018-05-22
International Publication Date
2018-11-22
International Renewal Date
2028-05-22
Auto Protection Date
2020-05-22
International Status
001 - Request for extension of protection established
International Status Date
2018-11-22
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event Date | Event Description |
2018-11-22 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2018-11-23 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-11-23 | ASSIGNED TO EXAMINER |
2018-11-27 | APPLICATION FILING RECEIPT MAILED |
2018-11-29 | NON-FINAL ACTION WRITTEN |
2018-11-30 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2018-12-13 | REFUSAL PROCESSED BY MPU |
2018-12-13 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2018-12-28 | REFUSAL PROCESSED BY IB |
2019-05-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-05-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-05-10 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-05-31 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-06-14 | ASSIGNED TO LIE |
2019-07-03 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-07-23 | PUBLISHED FOR OPPOSITION |
2019-07-23 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-10-08 | REGISTERED-PRINCIPAL REGISTER |
2020-01-08 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2020-02-03 | GENERIC MADRID TRANSACTION CREATED |
2020-02-03 | GENERIC MADRID TRANSACTION SENT TO IB |
2020-03-13 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2022-02-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2022-02-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2022-02-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2022-02-10 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
2022-02-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2022-02-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |